Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Heart Journal

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2008.05.024PMID 18946894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents.

  2007cited by this paper
• Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

  2007cited by this paper
• Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment

  2007cited by this paper
• Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice.

  2007cited by this paper
• Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study

  2006cited by this paper
• Drug-eluting stent thrombosis: increasingly recognized but too frequently overemphasized.

  2006cited by this paper
• [A new classification of coronary bifurcation lesions].

  2006cited by this paper
• Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.

  2006cited by this paper
• Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents

  2006cited by this paper
• Drug-eluting stent restenosis the pattern predicts the outcome.

  2006cited by this paper
• A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".

  2006cited by this paper
• Una clasificación simple de las lesiones coronarias en bifurcación

  2006cited by this paper
• Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

  2006cited by this paper
• Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.

  2006cited by this paper
• Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.

  2005cited by this paper
• Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents.

  2005cited by this paper
• Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

  2005cited by this paper
• Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation.

  2005cited by this paper
• Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

  2005cited by this paper
• The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.

  2005cited by this paper
• Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

  2005cited by this paper
• Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.

  2004cited by this paper
• Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions

  2004cited by this paper
• Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation.

  2002cited by this paper
• Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions.

  2000cited by this paper
• Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.

  1999cited by this paper
• Atlas of Interventional Cardiology

  1994cited by this paper

• Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations.

  2016cites this paper
• Comparison of abluminal biodegradable polymer biolimus‐eluting stents and durable polymer everolimus‐eluting stents in the treatment of coronary bifurcations

  2014cites this paper
• Interventional Treatments of Coronary Artery Bifurcations

  2014cites this paper
• First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations.

  2013cites this paper
• 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention

  2013cites this paper
• The long-term clinical outcome of T-stenting and small protrusion technique for coronary bifurcation lesions.

  2013cites this paper
• A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: results of the SINGLE KISS trial.

  2013cites this paper
• 15. Devices: TriReme

  2012cites this paper
• CORONARY ARTERY DISEASE Original Studies Sirolimus- Versus Paclitaxel-Eluting Stents for Coronary Bifurcations Intervention: A Meta-Analysis of Five Clinical Trials

  2012cites this paper
• Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial.

  2012cites this paper
• 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary

  2012cites this paper
• Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry

  2012cites this paper
• Drug eluting stenting in bifurcation coronary lesions long‐term results applying a systematic treatment strategy

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) PCI of complex coronary lesions , new stent technologies , and clinical outcomes

  2011cites this paper
• ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

  2011cites this paper
• Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

  2011cites this paper
• Sideguard® dedicated stent system for the treatment of coronary bifurcation artery lesions

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• Bifurcation lesion morphology and intravascular ultrasound assessment

  2011cites this paper
• Elective Double Stenting for Non–Left Main Coronary Artery Bifurcation Lesions: Patient Selection and Technique

  2010cites this paper
• Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry.

  2010cites this paper
• A RANDOMIZED COMPARISON OF SIROLIMUS- VERSUS PACLITAXEL-ELUTING STENT FOR TREATMENT OF BIFURCATION LESIONS BY SINGLE STENT AND KISSING BALLOONING: RESULTS OF SINGLE KISS TRIAL

  2010cites this paper
• Aktuelle Aspekte der modernen interventionellen Koronartherapie

  2010cites this paper
• The need for a dedicated bifurcation stenting system

  2009cites this paper
• Very long‐term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions

  2009cites this paper
• Stents farmacológicos para lesões em bifurcações: Outra indicação não aprovada (off-label) com resultados superiores aos dos stents não-farmacológicos

  2008cites this paper
• Medikamente freisetzende Koronarstents (DES) und Medikamente freisetzende Ballonkatheter (DEB): Aktualisierung des Positionspapiers der DGK

  2008cites this paper